Biopharma's stock market winners of 2022 revealed

Biopharma's stock market winners of 2022 revealed

5
(798)
Write Review
More
$ 24.50
Add to Cart
In stock
Description

Pipeline performers including Lilly, Daiichi and Sarepta topped the stock market gainers last year, as the Covid trade was thoroughly unwound.

Life Sciences 2023 Year End Review / 2024 Outlook - Gibson Dunn

Healthcare Industry News Weekly Wrap-Up: November 11, 2022

2023 Brand Entertainment Awards winners revealed

Evaluate Search

SBFM Stock Alert: Why Sunshine Biopharma Is Up 80% Today

Astrazeneca, GSK And PureTech Set Sights on $1.1trn Biopharma

Few biopharma risers stand out at the half year

Biopharmaceutical Market Size, Share and Analysis

PRWeek US Awards 2022 shortlist revealed

Evaluate Search

VC funding trends in biotechnology

Markets News, Oct. 3, 2023: Dow, S&P 500 Fall to 4-Month Lows as